EndoDrug: A new AI-based cell invasion platform for accelerated diagnosis and drug testing in endometriosis

• Unité de recherche: INNOSUISSE
• Numéro de projet: 125.876 IP-LS
• Titre du projet anglais: EndoDrug: A new AI-based cell invasion platform for accelerated diagnosis and drug testing in endometriosis

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

Endometriosis poses a significant global health burden with treatment progress limited by the lack of in vitro models that replicate early-stage cell invasion. EndoDrug addresses this need by developing an AI-assisted in vitro organoid invasion platform for endometriosis diagnosis and drug testing.